An integration of complementary strategies for gene expression analysis to reveal novel therapeutic opportunities for breast cancer
IntroductionA major objection in developing amassed emphatic therapeutic strategies for the treatment of breast cancer patients is confronting the heterogeneity of the disease, recognizing that breast cancer is not one disease on the contrary multiple disorders with distinct underlying mechanisms. Gene expression profiling studies have been used to dissect this complexity and our previous studies admit identified a series of intrinsic subtypes of breast cancer that define various populations of patients with respect to survival. Additional chore has as well used signatures of oncogenic road deregulation to dissect breast cancer heterogeneity as right as to suggest therapeutic opportunities linked to method activation.
MicroRNA expression profiling of male breast cancer
IntroductionMicroRNAs (miRNAs) are a assemblage of inconsequential noncoding RNAs that control gene expression by targeting mRNAs and triggering either translation repression or RNA degradation. Their aberrant word may be involved in human diseases, including cancer. To appraisal the speculation that there is a particular miRNA signal signature which characterizes male breast cancers, we performed miRNA microarray conversation in a series of adult breast cancers and compared them to cases of mainly gynecomastia and female breast cancers. Methods: Paraffin-blocks were obtained at the Branch of Pathology of Thomas Jefferson University from 28 subject patients including 23 breast cancers and 5 cases of virile gynecomastia, and 10 female ductal breast carcinomas.
Tumour aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment
IntroductionTo determine whether the levels of expression of 17 candidate genes were associated with loco-regional control after breast conserving treatments of early-stage breast cancers in young, premenopausal women. Methods: Gene expression was measured using RT-PCR in the breast tumors of a series of 53 boylike (<40 years), premenopausal patients. All treatments consisted in primary breast conserving surgery followed by whole-breast radiotherapy (+/- limited lymph nodes) with or without systemic treatments (chemotherapy +/- hormone-therapy). The median follow-up was 10 years. Results: The 10-year loco-regional polity rate was 70% (95% CI 57%-87%). In univariate analysis, no clinical/pathological prognostic factors were begin to be significantly associated with a decreased loco-regional control.
Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis
IntroductionSites of chronic inflammation are regularly associated with the establishment and advance of manifold malignancies including breast cancer. A common inflammatory condition in humans is autoimmune arthritis (AA) that causes inflammation and deformity of the joints. Other systemic effects associated with arthritis include increased cellular infiltration and inflammation of the lungs. Assorted studies have reported statistically compelling risk ratios between AA and breast cancer. In spite of this knowledge, available for a decade, it has never been questioned whether the site of chronic inflammation linked to AA creates a milieu that attracts tumor cells to national and come in the inflamed bones and lungs which are frequent sites of breast cancer metastasis.
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by reverse-transcriptase polymerase chain reaction and comparison to status of bone marrow disseminated cells
IntroductionThe role of circulating tumor cells (CTC) in blood of salient breast cancer patients is still under investigation. We evaluated (1) the incidence of CTC in blood, (2) the correlation between CTC and disseminated tumour cells (DTC) in the bone gist (BM) and (3) we characterized CTC for the locution of HER2, the oestrogen receptor (ER) and the progesterone receptor (PR). Methods: Blood of 431 patients with essential breast cancer were analysed for EpCAM, MUC1 and HER2 transcripts with the AdnaTest BreastCancer (AdnaGen AG, Germany). Vocable of the ER and PR receptor was assessed in an fresh reverse-transcriptase polymerase chain reaction (RT-PCR).
TGFb and mutant-p53 Conspire to Induce Metastasis by Antagonizing p63: A ternary Complex Affair.
How and when a tumor acquires metastatic properties remain mainly unknown. Original business has uncovered an intricate current mechanism through which transforming fleshing out factor-beta (TGFβ ) acts in concerto with oncogenic Ras to antagonize p63-metastasis protective function. p63 inhibition requires the combined commotion of Ras-activated mutant p53 and TGFβ -induced Smads. Mechanistically, it involves the formation of a p63-Smads-mutant p53 ternary complex. Remarkably, just two of the answer downstream targets of p63 turn out to be sufficient as a prognostic object for breast cancer metastasis. Moreover, the molecular mechanism of this inhibition points to novel therapeutic possibilities.
Construction of a MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter NIS for gene therapy of breast cancer
IntroductionThe sodium iodide symporter (NIS) directs the uptake and concentration of iodide in thyroid cells. This in turn allows for radioiodine imaging and therapy of thyroid cancer. To extend the custom of NIS-mediated radioiodine therapy to other types of cancer, we compass successfully transferred and expressed the sodium-iodide symporter (NIS) gene in prostate, colon, and breast cancer cells both in vivo and in vitro using non-replicating adenoviral vectors. Methods: In course to civilize virotheraphy efficiency we developed a conditionally replicating adenovirus (CRAd) in which the transcriptional cassette RSV promoter-human NIScDNA-bGH polyA was too inserted at the E3 region.
The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition
IntroductionNotch is a family of transmembrane protein receptors whose activation requires proteolytic cleavage by gamma-secretase. On account of aberrant Notch signaling can induce mammary carcinomas in transgenic mice and great expression levels of Cut receptors and ligands correlate with overall deficient clinical outcomes, inhibiting gamma-secretase with bantam molecules may be a promising approach for breast cancer treatment. Consistent with this hypothesis, two recent papers reported that gamma-secretase inhibitor I (GSI I), Z-LLNle-CHO, is poisonous to breast cancer cells both in vitro and in vivo. In this study, we compared the existence and cytotoxicity of Z-LLNle-CHO to that of two highly particular GSIs, DAPT and L-685, 458 and three structurally unrelated proteasome inhibitors, MG132, lactacystin, and Bortezomib in disposition to study the mechanism underlying the cytotoxicity of Z-LLNle-CHO in breast cancer cells.
Sex steroid metabolism polymorphisms and mammographic density in pre- and early peri-menopausal women
IntroductionTo examine the society between mammographic density and single-nucleotide polymorphisms (SNPs) in genes encoding CYP1A1, CYP1B1, aromatase, 17beta-HSD, ESR1, and ESR2 in pre- and early peri-menopausal Caucasian, African-American, Chinese, and Japanese women. Methods: The Study of Women' s Health Across the Homeland is a longitudinal community-based cohort study. We analysed news from 451 pre- and early peri-menopausal participants of the ancillary SWAN Mammographic Density study for whom we had filled hookup regarding mammographic density, genotypes, and covariates. Using multivariate linear regression, we examined the relation between percent mammographic breast density (outcome) and everyone SNP (primary predictor), adjusting for age, race/ethnicity, parity, cigarette smoking, and thing bulk index (BMI).
A novel role for Signal Transducer and Activator of Transcription 5b STAT5b in beta1 integrin-mediated human breast cancer cell migration
IntroductionSignal transducer and activator of transcription (STAT) 5b is a transcription part involved in pro-proliferative and pro-survival signaling in a number of solid tumors, including breast cancer. The contribution of STAT5b to breast cancer cell motility has not been explored. This donkeywork aims to elucidate the role of STAT5b in breast cancer cell migration. Methods: STAT5b was knocked down using siRNA in two aggressive, highly migratory breast cancer cell lines (BT-549 and MDA-MB-231), and transwell migration assays were performed to bias the consequence of STAT5b for their migration. Knockdown-rescue experiments were utilized to validate the specificity of STAT5b knockdown and impel which regions/function of STAT5b are necessary for its role in migration.
